Company Filing History:
2 out of 832,843 Years Active: 2013-2014
Title: Miriam Ruberg: Innovator in Aminotetraline Derivatives
Introduction
Miriam Ruberg is a notable inventor based in Neustadt, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her work on amino tetraline derivative compounds. With a total of 2 patents, her innovations are aimed at addressing various medical conditions.
Latest Patents
Miriam's latest patents focus on amino tetraline derivatives. The first patent application relates to amino tetraline derivative compounds and methods of use, specifically detailing compounds of formula (I) and their pharmaceutically acceptable salts and solvates. This application emphasizes the potential of these compounds in producing medicaments for the treatment of movement disorders and central nervous system disorders. The second patent also pertains to compounds of formula (I) and their applications in creating medicaments for various diseases, particularly those affecting the central nervous system.
Career Highlights
Throughout her career, Miriam Ruberg has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to significantly impact the treatment of neurological disorders, showcasing her dedication to improving patient outcomes.
Collaborations
Miriam has collaborated with esteemed colleagues such as Peter Gmeiner and Harald Huebner. These partnerships have likely enriched her research and contributed to the success of her patent applications.
Conclusion
Miriam Ruberg stands out as a pioneering inventor in the field of medicinal chemistry, with her work on amino tetraline derivatives paving the way for new treatments. Her contributions are invaluable to the scientific community and hold promise for future advancements in medicine.